Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Adicionar filtros








Intervalo de ano
1.
Zhongguo dangdai erke zazhi ; Zhongguo dangdai erke zazhi;(12): 98-102, 2024.
Artigo em Chinês | WPRIM | ID: wpr-1009900

RESUMO

Multisystem inflammatory syndrome in children (MIS-C) is a complex syndrome characterized by multi-organ involvement that has emerged in the context of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak. The clinical presentation of MIS-C is similar to Kawasaki disease but predominantly presents with fever and gastrointestinal symptoms, and severe cases can involve toxic shock and cardiac dysfunction. Epidemiological findings indicate that the majority of MIS-C patients test positive for SARS-CoV-2 antibodies. The pathogenesis and pathophysiology of MIS-C remain unclear, though immune dysregulation following SARS-CoV-2 infection is considered a major contributing factor. Current treatment approaches for MIS-C primarily involve intravenous immunoglobulin therapy and symptomatic supportive care. This review article provides a comprehensive overview of the definition, epidemiology, pathogenesis, clinical presentation, diagnosis, treatment, and prognosis of MIS-C.


Assuntos
Criança , Humanos , COVID-19 , SARS-CoV-2 , Pandemias , Síndrome de Resposta Inflamatória Sistêmica/terapia
2.
Yao Xue Xue Bao ; (12): 469-482, 2023.
Artigo em Chinês | WPRIM | ID: wpr-965609

RESUMO

Ribonucleic acid (RNA) medicines have strong therapeutic potential for numerous rare genetic illnesses and malignancies because of its exact programmability based on Watson-Crick base pairing principle and unique ability to regulate gene expression. However, RNA medicines still have limitations in many areas, including stability, half-life time, immunogenicity, organ selectivity, cellular uptake and endosomal escape efficiency despite their great therapeutic potentials. This review briefly introduced numerous RNA medications [mostly messenger RNA (mRNA), small interfering RNA (siRNA), microRNA (miRNA) and antisense oligonucleotide (ASO)] that have intrigued of researchers in recent years, as well as their action mechanism in vivo. A number of delivery techniques, such as chemical modification, ligands coupling and nanocarriers have been proposed. The manufacture and applications of lipid nanoparticle, polymer nanoparticle and exosomes were discussed in depth. The goal of this work is to give a theoretical foundation and design concepts for the development of effective and safe RNA delivery technology, as well as to facilitate RNA therapeutic clinical translation.

3.
Chin. med. j ; Chin. med. j;(24): 2057-2064, 2011.
Artigo em Inglês | WPRIM | ID: wpr-319147

RESUMO

<p><b>BACKGROUND</b>Hepatocellular carcinoma (HCC) is a common primary cancer frequently associated with hepatitis B virus (HBV) infection. However, whether these identified genes are particularly associated with HBV-related HCC remains unknown. The aim of this study was to investigate the differential gene expression between HBV-related HCC tissues and adjacent noncancerous tissues.</p><p><b>METHODS</b>cDNA microarray was used to detect the differential gene expression profile in the HBV-related HCC tissues and adjacent noncancerous tissues, and reverse transcription-polymerase chain reaction (RT-PCR) was performed to verify the differential expression of candidate genes obtained from cDNA microarray experiment.</p><p><b>RESULTS</b>In this study, 1369 genes or expressed sequence tags (ESTs) including 121 genes or ESTs with at least two-fold expression alterations between cancerous and noncancerous tissues were identified. Special AT-rich sequence binding protein 1 (SATB-1) expression was positive in 73% (16/22) of cancerous tissues and negative (0/22) in all noncancerous tissues of HBV-related HCC patients. Transmembrane 4 superfamily member 1 (TM4SF-1) expression was positive in 86% (19/22) of cancerous tissues and negative (0/22) in all noncancerous tissues. Suppression of tumorigenicity 14 (ST-14) expression was positive in 73% (16/22) of noncancerous tissues in patients with HBV-related HCC and negative in all HCC tissues (0/22).</p><p><b>CONCLUSION</b>This study provided the gene expression profile of HBV-related HCC and presented differential expression patterns of SATB-1, TM4SF-1 and ST-14 between cancerous and noncancerous tissues in patients with HBV-related HCC.</p>


Assuntos
Adulto , Idoso , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Adulto Jovem , Antígenos de Superfície , Genética , Carcinoma Hepatocelular , Genética , Virologia , Regulação Neoplásica da Expressão Gênica , Vírus da Hepatite B , Virulência , Proteínas de Ligação à Região de Interação com a Matriz , Genética , Proteínas de Neoplasias , Genética , Análise de Sequência com Séries de Oligonucleotídeos
4.
Chin. med. j ; Chin. med. j;(24): 2260-2263, 2007.
Artigo em Inglês | WPRIM | ID: wpr-255801

RESUMO

<p><b>BACKGROUND</b>Alleviation of microcirculation disorders in severe acute pancreatitis (SAP) can improve survival rates, and low molecular weight heparin (LMWH) is well known to have potent ameliorative effect on microcirculation disorders caused by anti-coagulant activity. The aim of this study was to investigate the effects of LMWH on pancreatic microcirculation in SAP in rats.</p><p><b>METHODS</b>SD rats were randomly divided into 3 groups: sham operation (S) group, SAP group, and LMWH treatment (LT) group. The concentrations of serum amylase, tumor necrosis factor-alpha (TNF-alpha), endothelin-1 (ET-1), pancreatic ultrastructure were examined at 24 hours after the models were set up in each group.</p><p><b>RESULTS</b>Compared with S group, the concentration of serum amylase, ET-1, and TNF-alpha in SAP group were significantly increased (P < 0.001); After LMWH treatment, the concentration of serum amylase, ET-1, TNF-alpha were decreased significantly compared with SAP group (P < 0.001, 0.01, 0.001, respectively). On electron microscopy, the microthrombosis in LT group was significantly less than that in SAP group. The 3-day survival rate in SAP group (25.0%) was significantly lower than that in S group (100.0%, P < 0.05) and in LT group (87.5%, P < 0.05).</p><p><b>CONCLUSIONS</b>The disorder of pancreatic microcirculation may be involved in the inflammatory response of rats with SAP. LMWH can effectively improve the survival rate of SAP, and alleviate the severity of microcirculation disorders through its antithrombin effects and down-regulate the levels of serum ET-1 and TNF-alpha.</p>


Assuntos
Animais , Ratos , Doença Aguda , Anticoagulantes , Farmacologia , Modelos Animais de Doenças , Endotelina-1 , Sangue , Heparina de Baixo Peso Molecular , Farmacologia , Microcirculação , Microscopia Eletrônica , Pâncreas , Patologia , Pancreatite , Sangue , Tratamento Farmacológico , Ratos Sprague-Dawley , Taxa de Sobrevida , Fator de Necrose Tumoral alfa , Sangue
5.
Zhonghua ganzangbing zazhi ; Zhonghua ganzangbing zazhi;(12): 231-233, 2004.
Artigo em Chinês | WPRIM | ID: wpr-260052

RESUMO

<p><b>OBJECTIVE</b>To identify proteomic patterns in hepatic tissues for diagnosing early HBV related HCC.</p><p><b>METHODS</b>Proteomic spectra were generated by two-dimensional gel electrophoresis (2-DE), A preliminary "raining" set of spectra derived from analysis of 14 cancer tissues and 14 non-cancer tissues, a proteomic patterns that completely discriminated cancer from non-cancer was identified. The discovered pattern was then used to classify an independent set of 48 masked samples: 24 from cancer tissues, and 24 from non-cancer tissues.</p><p><b>RESULTS</b>The discriminatory pattern correctly identified all cancer tissues and non-cancer tissues in the masked set. This result yielded a sensitivity of 100%, specificity of 100%.</p><p><b>CONCLUSION</b>Further analysis on these proteins in the proteomic pattern will be helpful to screen tumor markers for HBV related HCC. These findings justify a prospective assessment of proteomic pattern technology as a screening tool for cancer in high-risk and general populations.</p>


Assuntos
Humanos , Carcinoma Hepatocelular , Diagnóstico , Hepatite B , Fígado , Química , Neoplasias Hepáticas , Diagnóstico , Proteínas de Neoplasias , Proteômica
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA